DSP Entities Trim Stake in Alembic Pharma via Open Market Sale
Alembic Pharmaceuticals Ltd 路 Acquisition/ Disposal of Shares 路 29 Sept 2026, 5:02 pm
DSP Entities Trim Stake in Alembic Pharma via Open Market Sale DSP Trustee Pvt Ltd and PACs trimmed their combined stake in Alembic Pharma Ltd to 2.97% (58,31,766 shares) from 3.04% (59,68,340 shares) following an open-market disposal of 1,36,574 equity shares (0.07% of paid-up capital) on 24th Sep'26. The sale was executed via DSP Mid Cap Fund and DSP India Equity Fund (ICAV), triggering a Regulation 29(2) disclosure as cumulative holding changes breached the 2% reporting threshold since previous disclosures. Total voting capital post-transaction stands at 19,65,63,124 shares (Rs 39.31 cr paid-up capital).
Original exchange filing (PDF)
More announcements from Alembic Pharmaceuticals Ltd
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets, 15 mg and 45 mg. 路 15 Nov 2026
- Please find attached herewith the Transcript of Post Results Conference Call held on 4th November, 2026. 路 10 Nov 2026
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). 路 05 Nov 2026
- Please find attached Audio Recording of Investor Call. 路 05 Nov 2026
- Please find attached intimation under Regulation 30(5) of SEBI (LODR) Regulations, 2015. 路 04 Nov 2026
- Please find attached Press Release 路 04 Nov 2026
- Please find attached Investor Presentation for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
- Please find attached Press Release for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
